397 related articles for article (PubMed ID: 31988048)
1. Dysregulation of microRNA-125a contributes to obesity-associated insulin resistance and dysregulates lipid metabolism in mice.
Liu R; Wang M; Li E; Yang Y; Li J; Chen S; Shen WJ; Azhar S; Guo Z; Hu Z
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May; 1865(5):158640. PubMed ID: 31988048
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-26a regulates insulin sensitivity and metabolism of glucose and lipids.
Fu X; Dong B; Tian Y; Lefebvre P; Meng Z; Wang X; Pattou F; Han W; Wang X; Lou F; Jove R; Staels B; Moore DD; Huang W
J Clin Invest; 2015 Jun; 125(6):2497-509. PubMed ID: 25961460
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-125a-5p Mediates 3T3-L1 Preadipocyte Proliferation and Differentiation.
Xu Y; Du J; Zhang P; Zhao X; Li Q; Jiang A; Jiang D; Tang G; Jiang Y; Wang J; Li X; Zhang S; Zhu L
Molecules; 2018 Feb; 23(2):. PubMed ID: 29393878
[TBL] [Abstract][Full Text] [Related]
4. Induction of miR-96 by Dietary Saturated Fatty Acids Exacerbates Hepatic Insulin Resistance through the Suppression of INSR and IRS-1.
Yang WM; Min KH; Lee W
PLoS One; 2016; 11(12):e0169039. PubMed ID: 28036389
[TBL] [Abstract][Full Text] [Related]
5. Saturated fatty acid-induced miR-195 impairs insulin signaling and glycogen metabolism in HepG2 cells.
Yang WM; Jeong HJ; Park SY; Lee W
FEBS Lett; 2014 Nov; 588(21):3939-46. PubMed ID: 25240198
[TBL] [Abstract][Full Text] [Related]
6. MiR-17 family-mediated regulation of Pknox1 influences hepatic steatosis and insulin signaling.
Ye D; Lou G; Zhang T; Dong F; Liu Y
J Cell Mol Med; 2018 Dec; 22(12):6167-6175. PubMed ID: 30338914
[TBL] [Abstract][Full Text] [Related]
7. miR-188 promotes liver steatosis and insulin resistance via the autophagy pathway.
Liu Y; Zhou X; Xiao Y; Li C; Huang Y; Guo Q; Su T; Fu L; Luo L
J Endocrinol; 2020 Jun; 245(3):411-423. PubMed ID: 32252024
[TBL] [Abstract][Full Text] [Related]
8. Hepatic miR-125b inhibits insulin signaling pathway by targeting PIK3CD.
Du X; Li X; Chen L; Zhang M; Lei L; Gao W; Shi Z; Dong Y; Wang Z; Li X; Liu G
J Cell Physiol; 2018 Aug; 233(8):6052-6066. PubMed ID: 29319168
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: Novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease.
Lin Y; Ding D; Huang Q; Liu Q; Lu H; Lu Y; Chi Y; Sun X; Ye G; Zhu H; Wei J; Dong S
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):869-882. PubMed ID: 28483554
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.
Wang XC; Zhan XR; Li XY; Yu JJ; Liu XM
World J Gastroenterol; 2014 Dec; 20(47):17914-23. PubMed ID: 25548489
[TBL] [Abstract][Full Text] [Related]
11. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
Liu X; Chen S; Zhang L
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
[TBL] [Abstract][Full Text] [Related]
12. A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet.
Zhang T; Zhao X; Steer CJ; Yan G; Song G
Metabolism; 2018 Aug; 85():183-191. PubMed ID: 29625129
[TBL] [Abstract][Full Text] [Related]
13. miR-125a-5p ameliorates hepatic glycolipid metabolism disorder in type 2 diabetes mellitus through targeting of STAT3.
Xu L; Li Y; Yin L; Qi Y; Sun H; Sun P; Xu M; Tang Z; Peng J
Theranostics; 2018; 8(20):5593-5609. PubMed ID: 30555566
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia.
Ng R; Wu H; Xiao H; Chen X; Willenbring H; Steer CJ; Song G
Hepatology; 2014 Aug; 60(2):554-64. PubMed ID: 24677249
[TBL] [Abstract][Full Text] [Related]
16. Effect and possible mechanisms of dioscin on ameliorating metabolic glycolipid metabolic disorder in type-2-diabetes.
Xu LN; Yin LH; Jin Y; Qi Y; Han X; Xu YW; Liu KX; Zhao YY; Peng JY
Phytomedicine; 2020 Feb; 67():153139. PubMed ID: 31881477
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis.
Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G
J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte ELOVL Fatty Acid Elongase 6 Determines Ceramide Acyl-Chain Length and Hepatic Insulin Sensitivity in Mice.
Matsuzaka T; Kuba M; Koyasu S; Yamamoto Y; Motomura K; Arulmozhiraja S; Ohno H; Sharma R; Shimura T; Okajima Y; Han SI; Aita Y; Mizunoe Y; Osaki Y; Iwasaki H; Yatoh S; Suzuki H; Sone H; Takeuchi Y; Yahagi N; Miyamoto T; Sekiya M; Nakagawa Y; Ema M; Takahashi S; Tokiwa H; Shimano H
Hepatology; 2020 May; 71(5):1609-1625. PubMed ID: 31529722
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p.
Zhang B; Li H; Li D; Sun H; Li M; Hu H
Gene; 2019 Jun; 700():139-148. PubMed ID: 30898698
[TBL] [Abstract][Full Text] [Related]
20. Genipin alleviates high-fat diet-induced hyperlipidemia and hepatic lipid accumulation in mice via miR-142a-5p/SREBP-1c axis.
Zhong H; Chen K; Feng M; Shao W; Wu J; Chen K; Liang T; Liu C
FEBS J; 2018 Feb; 285(3):501-517. PubMed ID: 29197188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]